Strem Brian M. 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Aug 2, 2021
Insider Transaction Report
Form 4
Strem Brian M.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2021-07-26+100,000→ 100,000 totalExercise: $3.12Exp: 2031-07-26→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 26, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.